Clinical trial
A Bridged Phase 1, Randomized, Double-blind, Placebo-controlled Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Multiple Dose of MN-08 in Healthy Subjects
NCT05660863 is registered in ClinicalTrials.gov with Guangzhou Magpie Pharmaceuticals Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Bridged Phase 1, Randomized, Double-blind, Placebo-controlled Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Multiple Dose of MN-08 in Healthy Subjects
- Lead sponsor
- Guangzhou Magpie Pharmaceuticals Co., Ltd.
- Phase
- Phase 1
- Overall status
- Not yet recruiting
- Start date
- September 1, 2027
- Completion date
- June 1, 2028
- Enrollment
- 16 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.